Bianco, Gabriele
 Distribuzione geografica
Continente #
NA - Nord America 2.712
EU - Europa 2.104
AS - Asia 1.005
SA - Sud America 68
AF - Africa 23
OC - Oceania 15
Continente sconosciuto - Info sul continente non disponibili 1
Totale 5.928
Nazione #
US - Stati Uniti d'America 2.664
IT - Italia 1.200
SG - Singapore 356
CN - Cina 209
IE - Irlanda 200
SE - Svezia 170
FR - Francia 79
DE - Germania 76
UA - Ucraina 59
VN - Vietnam 54
JP - Giappone 53
IN - India 50
GB - Regno Unito 43
BR - Brasile 40
HK - Hong Kong 40
ID - Indonesia 40
IR - Iran 39
NL - Olanda 36
FI - Finlandia 35
AT - Austria 33
PK - Pakistan 29
KR - Corea 28
BE - Belgio 26
CA - Canada 25
TH - Thailandia 24
TW - Taiwan 23
ES - Italia 22
CH - Svizzera 17
BY - Bielorussia 16
PL - Polonia 16
PT - Portogallo 16
RU - Federazione Russa 16
TR - Turchia 16
MX - Messico 15
AU - Australia 14
NG - Nigeria 13
CO - Colombia 9
PE - Perù 9
PH - Filippine 9
GR - Grecia 8
MY - Malesia 8
RO - Romania 8
AR - Argentina 6
DK - Danimarca 6
IL - Israele 6
CR - Costa Rica 5
SA - Arabia Saudita 5
BG - Bulgaria 4
NO - Norvegia 4
AZ - Azerbaigian 3
CZ - Repubblica Ceca 3
EG - Egitto 3
HR - Croazia 3
KZ - Kazakistan 3
RS - Serbia 3
CL - Cile 2
CU - Cuba 2
IQ - Iraq 2
LT - Lituania 2
QA - Qatar 2
TG - Togo 2
TZ - Tanzania 2
AM - Armenia 1
BD - Bangladesh 1
EU - Europa 1
HU - Ungheria 1
KE - Kenya 1
KG - Kirghizistan 1
LI - Liechtenstein 1
LK - Sri Lanka 1
MA - Marocco 1
MK - Macedonia 1
NP - Nepal 1
NZ - Nuova Zelanda 1
PA - Panama 1
SC - Seychelles 1
TM - Turkmenistan 1
UY - Uruguay 1
VE - Venezuela 1
Totale 5.928
Città #
Chandler 491
Santa Clara 293
Singapore 272
Dublin 192
Ashburn 128
Torino 106
Turin 106
Nyköping 95
Fairfield 78
Columbus 61
Houston 60
Milan 58
Medford 56
Redwood City 51
Seattle 50
Princeton 47
Wilmington 44
Hangzhou 41
Rome 41
Beijing 39
Woodbridge 37
Jakarta 33
Los Angeles 32
Vienna 28
Dong Ket 27
Dallas 26
Helsinki 26
Dearborn 24
Ann Arbor 23
Washington 23
Cambridge 21
Karachi 19
Guangzhou 16
Pisa 16
Boston 15
Brussels 15
Bologna 12
Chicago 12
Fremont 12
New York 12
San Diego 11
Abuja 10
Bergamo 10
Central 10
Nanjing 10
Negrar 10
Norwalk 10
Tokyo 10
Alessandria 9
Asolo 9
Florence 9
Gothenburg 9
Manchester 9
Seoul 9
Shanghai 9
Taipei 9
Warsaw 9
Bangkok 8
Jacksonville 8
Munich 8
Naples 8
Padova 8
Andover 7
Frankfurt am Main 7
Guiyang 7
Istanbul 7
Lucca 7
Mexico City 7
Paris 7
Toronto 7
Villeurbanne 7
Ankara 6
Asti 6
Athens 6
Buffalo 6
Gorizia 6
Hamilton 6
Hebei 6
Hong Kong 6
Jinan 6
London 6
Mumbai 6
Napoli 6
Nuremberg 6
Perugia 6
Trieste 6
Verona 6
Caserta 5
Catania 5
Delhi 5
Gent 5
Glasgow 5
Hanoi 5
Kowloon City 5
Lima 5
Macerata 5
Madrid 5
Palermo 5
Rio Saliceto 5
San José 5
Totale 3.164
Nome #
RICERCA DI BARTONELLA HENSELAE IN DIFFERENTI CAMPIONI CLINICI DI PAZIENTI CON SOSPETTA MALATTIA DA GRAFFIO DI GATTO MEDIANTE INDAGINE MOLECOLARE E SIEROLOGICA 867
Parvimonas micra bacteremia following endoscopic retrograde cholangiopancreatography: A new route of infection 392
Septic shock due to meropenem- and colistin-resistant Cupriavidus pauculus 325
Exposure to the agricultural fungicide tebuconazole promotes Aspergillus fumigatus cross-resistance to clinical azoles. [Comini S. is the co-first author; Banche G. is the corresponding author; Cuffini A.M. is the co-corresponding author] 311
Enhanced Antimicrobial and Antibiofilm Effect of New Colistin-Loaded Human Albumin Nanoparticles (Scutera S and Argenziano M co-first authors, Musso T corresponding author) 198
Accuracy of the ELITe MGB® assays for the detection of carbapenemases, CTX-M, Staphylococcus aureus and mecA/C genes directly from respiratory samples 189
Nanofilm: a new drug delivery system to counteract Multi Drug Resistant Gram negative bacteria infections 180
Serological and molecular detection of Bartonella henselae in specimens from patients with suspected cat scratch disease in Italy: A comparative study [*V. Allizond and C. Costa contributed equally to this work; ** G. Banche is the corresponding author] 145
IN VITRO DALBAVANCIN ACTIVITY AGAINST CLINICAL ISOLATES OF STAPHYLOCOCCUS SPP. AND SUBSEQUENT INTERACTION WITH HUMAN PHAGOCYTES 138
Evaluation of the Amplex eazyplex SuperBug Acineto test for direct detection of multidrug- resistant Acinetobacter baumannii bloodstream infections in high endemicity settings [S. Comini is the corresponding author] 136
Development of an EliSPOT assay for HSV-1 and clinical validation in lung transplant patients 125
Evaluation of Bartonella henselae by molecular and serological assays in different clinical specimens from patients with suspected cat scratch disease 105
Activity of ceftolozane-tazobactam, ceftazidime-avibactam, meropenem-vaborbactam, cefiderocol and comparators against Gram-negative organisms causing bloodstream infections in Northern Italy (2019-2021): emergence of complex resistance phenotypes. 100
Cytomegalovirus and Epstein-Barr Virus DNA Kinetics in Whole Blood and Plasma of Allogeneic Hematopoietic Stem Cell Transplantation Recipients 93
Rubella serosurvey and factors related to vaccine hesitancy in childbearing women in Italy 93
Kinetics of cytomegalovirus and Epstein-Barr virus DNA in whole blood and plasma of kidney transplant recipients: Implications on management strategies 93
Early Post-Transplant Torquetenovirus Viremia Predicts Cytomegalovirus Reactivations In Solid Organ Transplant Recipients 91
Influenza and respiratory syncytial virus infections in the oldest-old continent 86
Bloodstream infection by two subpopulations of Klebsiella pneumoniae ST1685 carrying KPC-33 or KPC-14 following ceftazidime/avibactam treatment: Considerations regarding acquired heteroresistance and choice of carbapenemase detection assay 85
Detection of Carbapenemase and CTX-M Encoding Genes Directly from Bronchoalveolar Lavage Using the CRE and ESBL ELITe MGB Assays: Toward Early and Optimal Antibiotic Therapy Management of Critically Ill Patients with Pneumonia 82
Direct detection of extended‑spectrum‑β‑lactamase‑producers in Enterobacterales from blood cultures: a comparative analysis 81
Ceftazidime-avibactam susceptible to resistant KPC-producing Enterobacterales bloodstream infections: an observational study 76
RESIST-5 O.O.K.N.V. and NG-Test Carba 5 assays for the rapid detection of carbapenemase-producing Enterobacterales from positive blood cultures: a comparative study 75
In vitro activity of cefiderocol against ceftazidime‑avibactam susceptible and resistant KPC‑producing Enterobacterales: cross‑resistance and synergistic effects 70
Bacterial etiology and antimicrobial resistance trends in ocular infections: A 30-year study, Turin area, Italy 69
Occurrence of multi-carbapenemases producers among carbapenemase-producing Enterobacterales and in vitro activity of combinations including cefiderocol, ceftazidime-avibactam, meropenem-vaborbactam, and aztreonam in the COVID-19 era 69
Changes in KPC-producing Klebsiella pneumoniae susceptibility from the pre- to ceftazidime-avibactam era 68
Renal Allograft Biopsies with Polyomavirus BK Nephropathy: Turin Transplant Center, 2015–19 65
Burden of primary influenza and respiratory syncytial virus pneumonia in hospitalized adults: insights from a two-year multi-centre cohort study (2017-2018) 65
Ralstonia mannitolilytica bacteraemia: a case report and literature review 63
Evaluation of the NG-Test CTX-M MULTI immunochromatographic assay for the rapid detection of CTX-M extended-spectrum-ß-lactamases producers from positive blood cultures. 60
Direct Ethylenediaminetetraaceticacid-Modified β-Lactam Inactivation Method: An Improved Method to Identify Serine-Carbapenemase-, Metallo-β-Lactamase-, and Extended-Spectrum-β-Lactamase-Producing Enterobacterales Directly from Positive Blood Culture 58
Direct beta-lactam inactivation method: a new low-cost assay for the rapid detection of carbapenemase- or extended-spectrum- beta-lactamase-producing Enterobacterales directly from positive blood culture bottles. 58
Carbapenemase detection testing in the era of ceftazidime/avibactam-resistant KPC-producing Enterobacterales: A 2-year experience. 56
Meropenem/vaborbactam-based combinations against KPC-producing Klebsiella pneumoniae and multidrug-resistant Pseudomonas aeruginosa 55
Evaluation of a diagnostic algorithm for rapid identification of Gram-negative species and detection of extended-spectrum β-lactamase and carbapenemase directly from blood cultures 52
Fast-track identification of CTX-M-extended-spectrum-β-lactamase- and carbapenemase-producing Enterobacterales in bloodstream infections: implications on the likelihood of deduction of antibiotic susceptibility in emergency and internal medicine departments 52
Evaluation of CMV DNA in dried blood spot 49
Outbreak of ceftazidime-avibactam resistant KPC-producing Klebsiella pneumoniae in a COVID-19 Intensive Care Unit, Italy: urgent need for updating diagnostic protocols of surveillance cultures 49
Evaluation of an antigen-based test for hospital point-of-care diagnosis of SARS-CoV-2 infection 49
MALDI-TOF MS-Based Approaches for Direct Identification of Gram-Negative Bacteria and BlaKPC-Carrying Plasmid Detection from Blood Cultures: A Three-Year Single-Centre Study and Proposal of a Diagnostic Algorithm 46
Comparative virulence of seasonal viruses responsible for lower respiratory tract infections: a southern European multi-centre cohort study of hospital admissions 46
Activity of cefiderocol and synergy of novel β-lactam-β-lactamase inhibitor-based combinations against metallo-β-lactamase-producing gram-negative bacilli: insights from a two-year study (2019-2020) 45
Evaluation of BD Phoenix and Microscan WalkAway for determination of fosfomycin susceptibility in Staphylococcus aureus 44
Ceftazidime-avibactam resistance and restoration of carbapenem susceptibility in KPC-producing Klebsiella pneumoniae infections: A case series 43
Evaluation of synergistic activity of plazomicin-based combinations against KPC-producing Klebsiella pneumoniae with complex multidrug resistance phenotypes 42
Trueperella bernardiae bloodstream infection following onco-gynaecologic surgery and literature review 42
An Observational Study of MDR Hospital-Acquired Infections and Antibiotic Use during COVID-19 Pandemic: A Call for Antimicrobial Stewardship Programs. 39
Comparison of Three Different Commercial Methods for Fosfomycin Susceptibility Testing in Pseudomonas aeruginosa 39
Implementation of Chromatic Super CAZ/AVI® medium for active surveillance of ceftazidime-avibactam resistance: preventing the loop from becoming a spiral 37
Combination of Poly(ε-Caprolactone) Biomaterials and Essential Oils to Achieve Anti-Bacterial and Osteo-Proliferative Properties for 3D-Scaffolds in Regenerative Medicine 36
Looking beyond ceftazidime-avibactam resistance in KPC-producing Klebsiella pneumoniae: in vitro activity of the novel meropenem-vaborbactam in combination with the old fosfomycin 36
Increased blaKPC Copy Number and OmpK35 and OmpK36 Porins Disruption Mediated Resistance to Imipenem/ Relebactam and Meropenem/Vaborbactam in a KPC-Producing Klebsiella pneumoniae Clinical Isolate 33
Ceftazidime-Avibactam (C/A) Resistant, Meropenem Sensitive KPC-Producing Klebsiella pneumoniae in ICU Setting: We Are What We Are Treated with? 32
Impact of NG-Test CTX-M MULTI Immunochromatographic Assay on Antimicrobial Management of Escherichia coli Bloodstream Infections 30
Integrating rapid diagnostics in Gram-negative bloodstream infections of patients colonized by carbapenemase-producing Enterobacterales 30
Ten Years of KPC-Kp Bloodstream Infections Experience: Impact of Early Appropriate Empirical Therapy on Mortality 28
Multicentre Evaluation of the EUCAST Rapid Antimicrobial Susceptibility Testing (RAST) Extending Analysis to 16–20 Hours Reading Time 27
Assessment of rapid direct E-test on positive blood culture for same-day antimicrobial susceptibility 27
Persistently high-level polyomavirus BK replication in the absence of renal function abnormalities in a kidney transplant recipient 27
Light Scattering Technology and MALDI-TOF MS in the microbiological fast-track of bloodstream infections: potential impact on antimicrobial treatment choices in a real-life setting 25
Rapid determination of ceftazidime/avibactam susceptibility of carbapenemase-producing Enterobacterales directly from blood cultures: a comparative evaluation of EUCAST disc diffusion RAST and direct Etest® RAST 24
Prevalence and Impact on Mortality of Colonization and Super-Infection by Carbapenem-Resistant Gram-Negative Organisms in COVID-19 Hospitalized Patients 24
Anaerobic bloodstream infections in Italy (ITANAEROBY): A 5-year retrospective nationwide survey 22
Severity of RSV infection in Southern European elderly patients during two consecutive winter seasons (2017–2018) 22
Occurrence of adenovirus infection and clinical impact in paediatric stem cell transplant recipients 22
Detection of antibiotic resistance genes from blood cultures: performance assessment and potential impact on antibiotic therapy management 18
Rapid diagnostics and ceftazidime/avibactam for KPC-producing Klebsiella pneumoniae bloodstream infections: impact on mortality and role of combination therapy 17
Disc Diffusion and ComASP® Cefiderocol Microdilution Panel to Overcome the Challenge of Cefiderocol Susceptibility Testing in Clinical Laboratory Routine 17
First case of Chryseobacterium gallinarum bloodstream infection: a diagnostic and therapeutic challenge for an emerging pathogen 17
Multicentre Surveillance of Candida Species from Blood Cultures during the SARS-CoV-2 Pandemic in Southern Europe (CANCoVEU Project) 15
Performance evaluation of Bruker UMIC® microdilution panel and disc diffusion to determine cefiderocol susceptibility in Enterobacterales, Acinetobacter baumannii, Pseudomonas aeruginosa, Stenotrophomonas maltophilia, Achromobacter xylosoxidans and Burkolderia species 12
Enterobacterales carrying chromosomal AmpC β-lactamases in Europe (EuESCPM): Epidemiology and antimicrobial resistance burden from a cohort of 27 hospitals, 2020–2022 10
Prevalence and mortality of ceftazidime/avibactam-resistant KPC-producing Klebsiella pneumoniae bloodstream infections (2018–2022) 10
Synergistic Effect of Clinically Available Beta-Lactamase Inhibitors Combined with Cefiderocol against Carbapenemase-Producing Gram-Negative Organisms 10
null 10
Bloodstream Infections by Pantoea Species: Clinical and Microbiological Findings from a Retrospective Study, Italy, 2018–2023 9
Diagnostic methods and protocols for rapid determination of methicillin resistance in Staphylococcus aureus bloodstream infections: a comparative analysis 4
In Vivo Emergence of Ceftazidime/Avibactam, Cefiderocol and Aztreonam/Avibactam Cross-Resistance in a Patient With KPC-Producing Klebsiella pneumoniae Infection After Cefiderocol-Based Treatment 4
Updates on the Activity, Efficacy and Emerging Mechanisms of Resistance to Cefiderocol 3
In vivo development of resistance to novel β-lactam/β-lactamase inhibitor combinations in KPC-producing Klebsiella pneumoniae infections: a case series 3
Clinical and microbiological features of positive blood culture episodes caused by non-fermenting gram-negative bacilli other than Pseudomonas and Acinetobacter species (2020–2023) 3
Performance Evaluation of BD Phoenix and MicroScan WalkAway Plus for Determination of Fosfomycin Susceptibility in Enterobacterales 2
Detection of volatile organic compounds as new paradigm to accelerate antimicrobial susceptibility testing: performance evaluation of VITEK® REVEAL™ 2
Exposure to the agricultural fungicide tebuconazole promotes Aspergillus fumigatus cross-resistance to clinical azoles 2
From Forgotten Pathogen to Target for New Vaccines: What Clinicians Need to Know about Respiratory Syncytial Virus Infection in Older Adults 2
In vivo development of cefiderocol resistance in carbapenem-resistant Acinetobacter baumannii associated with the downregulation of a TonB-dependent siderophore receptor, PiuA 2
In vitro activity and genomic characterization of KPC-producing Klebsiella pneumoniae clinical blood culture isolates resistant to ceftazidime/avibactam, meropenem/vaborbactam, imipenem/relebactam: an Italian nationwide multicentre observational study (2022–23) 2
Complete Genome Sequence of a Klebsiella pneumoniae Strain Carrying Novel Variant blaKPC-203, Cross-Resistant to Ceftazidime/Avibactam and Cefiderocol, but Susceptible to Carbapenems, Isolated in Italy, 2023 1
Totale 6.116
Categoria #
all - tutte 22.802
article - articoli 0
book - libri 0
conference - conferenze 2.175
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 24.977


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/2020206 0 0 0 0 0 0 0 57 34 46 37 32
2020/2021614 27 90 50 27 28 39 37 72 58 57 43 86
2021/2022816 52 36 32 48 44 32 38 59 32 74 192 177
2022/20231.465 119 126 38 133 137 312 85 141 174 86 71 43
2023/2024914 78 111 74 66 68 121 61 41 25 75 82 112
2024/20251.250 50 163 106 164 383 140 117 127 0 0 0 0
Totale 6.116